ANNOUNCEMENT

Save $300 on MedCity CONVERGE Healthcare Innovation Summit July 9-10 in Philadelphia. Earlybird rate ends May 20.

East Coast accelerator DreamIt Ventures moving into healthcare IT

July 10, 2012 6:02 pm by | 0 Comments

Healthcare IT has become a new priority for East Coast accelerator DreamIt Ventures with the hire of a veteran angel investor group director.

Karen Griffith Gryga recently joined the accelerator’s Philadelphia office. Earlier this year it added a minority-led business component and started a program to work with startups based in Israel.

She has worked as executive director of Mid-Atlantic Angel Group, which has invested in life science and technology companies.

Although DreamIt has not shied away from healthcare startups in the past, with telemedicine company 1DocWay among the graduates of its New York class last year, it seems like it’s making a more concerted move into the space.

She spoke to MedCity News after taking part in an investor panel discussion at the MedCity CONVERGE conference. She talked about the move, how she’ll utilize her angel investor experience in the new role and the kind of investment opportunities she sees in healthcare.

Karen Griffith Gryga on joining DreamIt Ventures


On investment opportunities in healthcare

Copyright 2013 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Stephanie Baum

By Stephanie Baum

Stephanie Baum is the East Coast Innovation Reporter for MedCityNews.com. She enjoys covering healthcare startups across health IT, drug development and medical devices and innovations deployed to improve medical care. She graduated from Franklin & Marshall College in Pennsylvania and has worked across radio, print and video. She's written for The Christian Science Monitor, Dow Jones & Co. and United Business Media.
Visit website | More posts by Author

0 comments

Stay Up To Date

Recent Comments

Research Center

Jobs Board

Next Story
VCs say a coachable entrepreneur, strong IP make convergence worth investing in
Close